We report our preliminary experience in post-cardiac surgery mediastinitis using a recently introduced silver-releasing dressing claiming prompt antibacterial activity. Acticoat ᭧ , a silver nanoparticles slow release dressing was used in four patients with documented postcardiac surgery mediastinitis and persistently positive microbiological cultures despite vacuum-assisted closure (VAC) therapy. In all four patients negative cultures were obtained within a maximum of 72 h and patients were discharged within a maximum of 20 days.
Introduction
Mediastinitis following cardiac surgery is a relatively rare complication (1-3%) characterized, however, by a poor prognosis. Despite the introduction of new treatments which have contributed to improve clinical results, high mortality (10-40%) and relevant impact in terms of prolonged hospital stay and cost expense, are indeed still reported following such a complication. Here we report our preliminary experience with a silver-releasing dressing claiming prompt antibacterial activity that could be beneficial in reducing hospital stay and, therefore, cost expense in patients presenting with poststernotomy mediastinitis.
Materials and methods
Silver nanoparticles slow release dressing (Acticoat , ᭧ Smith and Nephew Medical Limited, Hull, England) was used in four patients presenting with the following characteristics: a) Documented mediastinitis according to the ACDC criteria; b) Persistent positive microbiological cultures despite specific i.v. antibiotics treatment and vacuumassisted closure (VAC) therapy (KCL, San Antonio, Texas, USA). Patient characteristics are summarized in Table 1 . Patients were readmitted to hospital after 25"9 days from the primary surgical procedure and all of them had positive microbiological culture at the time of readmission. Following the diagnosis of mediastinitis, all patients underwent initial debridement and VAC therapy combined with specific i.v. antibiotic treatment. After 9"2 days of treatment, however, due to the persistence of positive culture, *Corresponding author. Via San Vincenzo 38, 20123 Milano, Italy. Tel.: q39 3498465085.
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Acticoat dressing was used in order to enhance antimicro-᭧ bial activity.
Results
In patients ࠻1 and ࠻2 Acticoat was used as underlying dressing combined with VAC therapy (Fig. 1a) . In patient ࠻2 several holes were made in the Acticoat dressing before usage (Fig. 1b) to enhance drainage by VAC. In patients ࠻3 and ࠻4 Acticoat was used without concomitant VAC therapy. As shown in Table 1 , after a mean of 56"14 h, microbiological cultures were negative in all patients. Acticoat treatment was then suspended and, according to the surgeons choice and state of the wound, the treatment was completed with surgical or secondary closure (following a further period of VAC therapy in three out of four patients). All four patients were discharged home within a mean of 13"7 days from the first Acticoat medication.
Discussion
Management and treatment of post-sternotomy mediastinitis has been definitively influenced by the introduction of VAC therapy in 1997 w1x. However, despite favourable VAC therapy, effects have been clearly shown in terms of increased rate of granulation tissue and decreased exudates and wound size, clear favourable effects in decreasing bacterial counts have not been demonstrated yet.
Fuchs and colleagues w2x showed a significant improvement in antimicrobial activity using VAC therapy compared to povidon-iodine solution irrigation, however, the mean interval to obtain negative microbiological cultures using VAC remained for up to 16 days (range 10-26 days). Furthermore, no significant difference in complete wound healing time was shown using VAC therapy. Conversely, Weed and colleagues w3x demonstrated increased bacterial colony count during VAC therapy, thus questioning the correlation between bacterial clearances and wound healing rates. Furthermore, in final remarks of their study, Weed and colleagues mentioned the potential of a silverimpregnated sponge in decreasing bacterial load.
Based on this hypothesis and on previous in-vitro and in animal research evidences of strong antibacterial activity of silver nanocrystals slow release dressing w4, 5x, we decided to use Acticoat dressing in patients with postcardiac surgery mediastinitis and persistent positive cultures, despite VAC therapy. We initially combined Acticoat dressing to VAC therapy. This technique was previously described by Agarwal and colleagues in 2005 but no mention was made in their paper about specific indications for using Acticoat. Our experience with the first two patients demonstrated the feasibility of a combination of Acticoat and VAC therapy, however, in case of reduced amount of exudates, isolated use of Acticoat can also be pursued. Based on our preliminary results, we believe that the best option could be to utilize Acticoat dressing for a limited period (maximum 96 h), with or without VAC therapy (depending on the amount of exudates), as soon as the diagnosis of mediastinitis is clear, in order to achieve a prompt sterilization of the wound. Once bacterial clearance is completed, VAC therapy could be continued alone (or started if it was not combined) and proper surgical or secondary wound closure decided according to wound size. In our opinion this approach could optimize the management of poststernotomy mediastinitis allowing a prompt clearance of bacterial cultures and, therefore, a quicker action of VAC therapy on granulation tissue. More extensive experiences are, of course, mandatory to confirm the effect of such a combined approach in hospital stay and cost reduction.
